HNO International, Inc. filings document material agreements and capital-structure transactions for a Nevada corporation developing hydrogen-based energy technologies. Recent Form 8-K disclosures cover convertible promissory notes, common stock purchase warrants, an equity purchase agreement, promissory note extensions, and related placement-agent arrangements.
The company’s regulatory filings also record changes in its independent accountant, late-filing notifications on Form 12b-25, common-stock issuance mechanics, beneficial ownership limits, share reserve obligations, maturity dates, conversion terms, and going-concern language included in audit reporting. These documents provide formal disclosure around financing activity, reporting status, governance matters and risk-related accounting disclosures.
HNO International, Inc. filed a 10-K/A correcting prior year equity valuations and related disclosures. The company revised the valuation of service stock issuances from $0.001 to $0.23, which increased stock-based compensation expense by $1,108,368 and produced corresponding increases to additional paid-in capital and an adjustment to accumulated deficit. The amendment reverses an $82,500 intangible asset and $3,176 of related amortization following termination of a Patent Purchase Agreement and cancellation of 5,000,000 Series A preferred shares. The restatement reclassifies $21,560 of expenses to accounts payable and records the settlement of a $56,392 related‑party receivable through transferred equipment. The filing includes a going concern disclosure and restated 2023 net loss of $1,927,494, additional paid-in capital of $41,470,177, and an accumulated deficit of $(42,096,104).
HNO International, Inc. (HNOI) disclosed that its Board, after consulting management, concluded prior financial statements for the fiscal year ended October 31, 2024 and the interim periods ended January 31, 2025 and April 30, 2025 should no longer be relied upon due to errors in valuing service stock issuances and related stock-based compensation. The corrected valuation increases stock-based compensation expense by $1,108,368 for the fiscal year ended October 31, 2024 and by $4,827,055 for the quarter ended January 31, 2025, with the January adjustment carrying into the quarter ended April 30, 2025.
The company says these are non-cash adjustments that also increase additional paid-in capital and adjust accumulated deficit. HNOI intends to file Amendment No. 2 to its Annual Report for the fiscal year ended October 31, 2024 and Amendment No. 1 to its Quarterly Reports for the quarters ended January 31, 2025 and April 30, 2025, and management has discussed the matters with its independent registered public accounting firm.
HNO International, Inc. filed a Form 12b-25 to notify that its Quarterly Report on Form 10-Q for the period ended July 31, 2025 will be filed late. The company is finishing amendments to its Form 10-K for the year ended October 31, 2024 and its Form 10-Qs for the quarters ended January 31, 2025 and April 30, 2025. It states these amendments must be completed first to keep financial information consistent, and it expects to file the July 31, 2025 Form 10-Q within the extension period allowed by Rule 12b-25.